149 related articles for article (PubMed ID: 37748570)
1. Active ingredients of Chinese medicine with immunomodulatory properties: NF-κB pathway and Parkinson's disease.
Song J; Zhao Y; Shan X; Luo Y; Hao N; Zhao L
Brain Res; 2024 Jan; 1822():148603. PubMed ID: 37748570
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease.
Gorelenkova Miller O; Behring JB; Siedlak SL; Jiang S; Matsui R; Bachschmid MM; Zhu X; Mieyal JJ
Antioxid Redox Signal; 2016 Dec; 25(18):967-982. PubMed ID: 27224303
[TBL] [Abstract][Full Text] [Related]
3. NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson's disease models.
Liu Z; Shen C; Li H; Tong J; Wu Y; Ma Y; Wang J; Wang Z; Li Q; Zhang X; Dong H; Yang Y; Yu M; Wang J; Zhou R; Fei J; Huang F
J Neuroinflammation; 2023 Apr; 20(1):96. PubMed ID: 37072793
[TBL] [Abstract][Full Text] [Related]
4. Bear bile powder alleviates Parkinson's disease-like behavior in mice by inhibiting astrocyte-mediated neuroinflammation.
Wang L; Bai Y; Tao Y; Shen W; Zhou H; He Y; Wu H; Huang F; Shi H; Wu X
Chin J Nat Med; 2023 Sep; 21(9):710-720. PubMed ID: 37777320
[TBL] [Abstract][Full Text] [Related]
5. α-Cyperone protects dopaminergic neurons and inhibits neuroinflammation in LPS-induced Parkinson's disease rat model via activating Nrf2/HO-1 and suppressing NF-κB signaling pathway.
Huang B; Hu G; Zong X; Yang S; He D; Gao X; Liu D
Int Immunopharmacol; 2023 Feb; 115():109698. PubMed ID: 36634417
[TBL] [Abstract][Full Text] [Related]
6. Pro-survival and anti-inflammatory roles of NF-κB c-Rel in the Parkinson's disease models.
Wang Z; Dong H; Wang J; Huang Y; Zhang X; Tang Y; Li Q; Liu Z; Ma Y; Tong J; Huang L; Fei J; Yu M; Wang J; Huang F
Redox Biol; 2020 Feb; 30():101427. PubMed ID: 31986466
[TBL] [Abstract][Full Text] [Related]
7. NF-κB-Mediated Neuroinflammation in Parkinson's Disease and Potential Therapeutic Effect of Polyphenols.
Singh SS; Rai SN; Birla H; Zahra W; Rathore AS; Singh SP
Neurotox Res; 2020 Mar; 37(3):491-507. PubMed ID: 31823227
[TBL] [Abstract][Full Text] [Related]
8. Research on the signaling pathways related to the intervention of traditional Chinese medicine in Parkinson's disease:A literature review.
Jin X; Dong W; Chang K; Yan Y
J Ethnopharmacol; 2024 May; 326():117850. PubMed ID: 38331124
[TBL] [Abstract][Full Text] [Related]
9. Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson's Disease Mouse Models.
Park JE; Leem YH; Park JS; Kim DY; Kang JL; Kim HS
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457238
[TBL] [Abstract][Full Text] [Related]
10. NF-κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective.
Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Papadakis M; Jabir MS; Saad HM; Batiha GE
J Cell Mol Med; 2023 Jul; 27(13):1775-1789. PubMed ID: 37210624
[TBL] [Abstract][Full Text] [Related]
11. Isobavachalcone Attenuates MPTP-Induced Parkinson's Disease in Mice by Inhibition of Microglial Activation through NF-κB Pathway.
Jing H; Wang S; Wang M; Fu W; Zhang C; Xu D
PLoS One; 2017; 12(1):e0169560. PubMed ID: 28060896
[TBL] [Abstract][Full Text] [Related]
12. Advances in NURR1-Regulated Neuroinflammation Associated with Parkinson's Disease.
Al-Nusaif M; Lin Y; Li T; Cheng C; Le W
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555826
[TBL] [Abstract][Full Text] [Related]
13. Wuzi Yanzong Pill relieves MPTP-induced motor dysfunction and neuron loss by inhibiting NLRP3 inflammasome-mediated neuroinflammation.
Pan T; Xiao Q; Fan HJ; Xu L; Qin SC; Yang LX; Jin XM; Xiao BG; Zhang B; Ma CG; Chai Z
Metab Brain Dis; 2023 Oct; 38(7):2211-2222. PubMed ID: 37470879
[TBL] [Abstract][Full Text] [Related]
14. Microglia-specific knock-out of NF-κB/IKK2 increases the accumulation of misfolded α-synuclein through the inhibition of p62/sequestosome-1-dependent autophagy in the rotenone model of Parkinson's disease.
Rocha SM; Kirkley KS; Chatterjee D; Aboellail TA; Smeyne RJ; Tjalkens RB
Glia; 2023 Sep; 71(9):2154-2179. PubMed ID: 37199240
[TBL] [Abstract][Full Text] [Related]
15. CD44 deficiency represses neuroinflammation and rescues dopaminergic neurons in a mouse model of Parkinson's disease.
Wang Y; Li L; Wu Y; Zhang S; Ju Q; Yang Y; Jin Y; Shi H; Sun C
Pharmacol Res; 2022 Mar; 177():106133. PubMed ID: 35182746
[TBL] [Abstract][Full Text] [Related]
16. Nilotinib inhibits microglia-mediated neuroinflammation to protect against dopaminergic neuronal death in Parkinson's disease models.
Wu J; Xu X; Zheng L; Mo J; Jin X; Bao Y
Int Immunopharmacol; 2021 Oct; 99():108025. PubMed ID: 34364303
[TBL] [Abstract][Full Text] [Related]
17. Neuroinflammation in Parkinson's Disease and its Treatment Opportunities.
Çınar E; Tel BC; Şahin G
Balkan Med J; 2022 Sep; 39(5):318-333. PubMed ID: 36036436
[TBL] [Abstract][Full Text] [Related]
18. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220
[TBL] [Abstract][Full Text] [Related]
19. Erinacine A Prevents Lipopolysaccharide-Mediated Glial Cell Activation to Protect Dopaminergic Neurons against Inflammatory Factor-Induced Cell Death In Vitro and In Vivo.
Lee SL; Hsu JY; Chen TC; Huang CC; Wu TY; Chin TY
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054997
[No Abstract] [Full Text] [Related]
20. Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models.
Huang B; Liu J; Ju C; Yang D; Chen G; Xu S; Zeng Y; Yan X; Wang W; Liu D; Fu S
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
